Shares of Rigel Pharmaceuticals jumped more than 15% as the biotech company announced an exclusive $960 million collaboration with Eli Lilly to develop …
The stock market has been holding up remarkably well, but why? Against the backdrop of weak second quarter earnings results, investors are piling …
Buying a single share of tech giant Google will set you back a not inconsiderable $1386.32.
Rigel Pharmaceuticals’ (RIGL) long-suffering bulls finally have reason to celebrate: The stock is up nearly 11% in pre-market trading Wednesday after the company …
H.C.
It’s a big day for Rigel Pharmaceuticals (NASDAQ:RIGL). The drug maker has just announced that the FDA has approved its chronic immune thrombocytopenia (ITP) drug …
With SCPH standing before the FDA this summer and RIGL in less than two weeks’ time, two bulls are placing their bets behind these drug makers.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors have a smile on their faces Monday morning, after the drug maker announced that the FDA is currently …
Alkermes Plc All eyes today on Alkermes Plc (NASDAQ:ALKS) as the biopharmaceutical company announced positive phase 3 data for ALKS 5461, a pipeline drug …
Piper Jaffray and William Blair are joining the conversation on falling stocks Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and DXP Enterprises Inc (NASDAQ:DXPE) after volatile news has …
